CELZ (creativemedicaltechnology.com) Market Value to Book Value Ratio
The price-to-book ratio for Creative Medical Technology (CELZ) demonstrates a search for equilibrium as the company implements non-surgical treatments for injuries and sexual dysfunctions. 0.57 sets the current value of this metric. The management team is betting on the protection of intellectual property, however, the narrow profile of regenerative medicine creates high binary risks, tying the business's success to new patents.
CELZ (Creative Medical Technology): analytical breakdowns and indicator data
The development of cell therapy in partnership with clinics requires significant investment in intangible assets. The relative capitalization metric of Creative Medical Technology (CELZ) compares its market value to its tangible assets, revealing a premium or discount to the balance sheet. The current value of 0.57 reflects the balance between net asset value and market expectations. This chart demonstrates the level of investor confidence in regenerative projects, where low levels may signal undervaluation or risks of capital freeze.